#44: FastFun: Re: Inspire Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
Phase 3! How long is phase 3 last? |
November 30, 2007
11:44:40 AM |
#43: FastFun: Inspire Initiates Phase 3 Trial of Epinastine Nasal Spray for Allergic Rhinitis
Top-line Results Expected Second Quarter 2008
Inspire Pharmaceuticals,... |
November 30, 2007
11:42:36 AM |
#42: FastFun: Inspire Announces Oral Presentation of Phase 2 Epinastine Nasal Spray Data at American College of Allergy, Asthma & Immunology Meeting
Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that a presentation of... |
November 27, 2007
09:11:59 PM |
#41: NewsBot: ISPH News Inspire Announces Webcast of Presentation at Cowen and Company's 27th Annual Health Care Conference
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
March 6, 2007
04:30:00 AM |
#40: NewsBot: ISPH News Inspire Reports Fourth Quarter and Full Year 2006 Financial Results
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 27, 2007
04:30:00 AM |
#39: NewsBot: ISPH News Inspire to Present Data at 2007 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 23, 2007
04:30:00 AM |
#38: NewsBot: ISPH News Inspire Announces Webcast of Presentation at Susquehanna Healthcare Conference
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 22, 2007
04:30:00 AM |
#36: NewsBot: ISPH News Inspire Announces Executive Management Promotions
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 20, 2007
04:30:00 AM |
#37: NewsBot: ISPH News Inspire Announces Executive Management Promotions
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 20, 2007
04:30:00 AM |
#35: NewsBot: ISPH News Inspire Licenses AzaSite(TM) For Ocular Infections
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 16, 2007
04:30:00 AM |
#34: NewsBot: ISPH News Inspire Director Alan F. Holmer Resigns Board Position to Accept Senior Post in Bush Administration
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 13, 2007
01:30:00 PM |
#33: NewsBot: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2006 Financial Results
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
February 13, 2007
04:30:00 AM |
#32: NewsBot: ISPH News Inspire Provides Cystic Fibrosis Clinical Program Update
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today... |
January 16, 2007
04:30:00 AM |
#31: NewsBot: ISPH News Inspire Announces Dry Eye Program Update
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
January 4, 2007
04:30:00 AM |
#30: NewsBot: ISPH News Inspire Initiates Phase 2 14-Day Clinical Trial of Epinastine for Seasonal Allergic Rhinitis
DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH)... |
December 5, 2006
04:30:00 AM |
| 
| 
| 
| 
| 
| 
